ADA assay is designed to measure the anti-drug antibodies in
variety of biomatrix including serum and plasma. The
primary ADA bundle (NGBI + SBIII) is a collection recommend by AI system
which offers advanced power to maximize specific affinity binding between
reference drug and anti-drug antibodies, improve ADA drug tolerance, minimize
cross-reactivities and matrix interference, which effectively improve assay
performance.
